Alefacept in the treatment of psoriatic nail disease: A small case series

被引：22
作者：
Cassetty, CT
Alexis, AF
Shupack, JL
Strober, BE
机构：
[1] NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY 10016 USA
[2] Biogen Idec, Cambridge, MA USA
[3] Genentech Inc, San Francisco, CA 94080 USA
[4] Centocor Inc, Malvern, PA 19355 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2005年 / 52卷 / 06期
关键词：
D O I：
10.1016/j.jaad.2005.01.101
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：1101 / 1102
页数：2
相关论文
共 3 条
[1]   Treatment of psoriatic nails with topical cyclosporin:: A prospective, randomized placebo-controlled study [J].
Cannavò, SP ;
Guarneri, F ;
Vaccaro, M ;
Borgia, F ;
Guarneri, B .
DERMATOLOGY, 2003, 206 (02) :153-156
[2]   A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis [J].
Krueger, GG ;
Papp, KA ;
Stough, DB ;
Loven, KH ;
Gulliver, WP ;
Ellis, CN .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 47 (06) :821-833
[3]   Nail Psoriasis Severity Index: A useful tool for evaluation of nail psoriasis [J].
Rich, P ;
Scher, RK .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 49 (02) :206-212
1